| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |